I have financial relationships to disclose Consultant for: st Jude, Boston, Sorin, Biotronik, Medtronic, Sanofi, Merck, Menarin Research support

Size: px
Start display at page:

Download "I have financial relationships to disclose Consultant for: st Jude, Boston, Sorin, Biotronik, Medtronic, Sanofi, Merck, Menarin Research support"

Transcription

1 I have financial relationships to disclose Consultant for: st Jude, Boston, Sorin, Biotronik, Medtronic, Sanofi, Merck, Menarin Research support from: st Jude, Boston, Sorin, Biotronik, Medtronic, Sanofi, Merck, Menarin

2 Atrial Fibrillation and Sports. Hospital Clinic. Universitat de Barcelona

3 1777 competitive athletes without heart disease Mean age 24± 6 years Mean age at most recent assessment 33±6 mean time of sports involvement 6 years 61 % continued with the training during FU Pellicia et al. JACC 2005

4 In the thirties < 0.5% Pellicia et al. JACC 2005

5 Pellicia et al. JACC 2005

6 Lone atrial fibrillation in Marathon runners Hospital Clinic. Thorax Institute. University of Barcelona, Hospital del Mar. Autonomous University of Barcelona Institut Municipal Investigacions Mèdiques IMIM. Barcelona. Molina et al. Europace 2008

7 Methods 270 healthy men that ran the marathon in Barcelona in Control group: 305 healthy sedentary men < 300 Kcal/day of physical activity, recruited at the REGICOR study

8 In the forties 9/183 (5%) Molina et al. Europace 08

9 Lone atrial fibrillation in Marathon runners Adjusted for age and systolic blood pressure

10 In the sixties 15-18% Grimsmo J. Eur J Cardiovasc Prev Rehabil 17:

11 Athletes or vigorous exercise? Is there a threshold?

12 16921 participants at the Physicians Health Study Healthy individuals 12 years follow up

13

14

15 70 patients with lone AF younger than 65y. Regular sport practice 65% among patients with AF and 15% in the general male population of individuals younger than 65 in Catalonia (REGICOR study)

16 Hospital Clínic. University of Barcelona. Institut Municipal d Investigacions Mèdiques de Barcelona. Int J Cardiol 2005

17 Logistic Regression Analysis Vagal Atrial Fibrillation Cases/Controls OR (95% CI) P Sport Practice 17/ ( ) 0.09 Current Sport Practice 6/ ( ) Lifetime hours hours 3/ (0.25-7) NS hours 7/ ( ) Current practice > 1500 hours (3 hours/week, 10 years 6/ ( ) 0.016

18 Is sports related lone AF a familial disease?

19 Familial Atrial Fibrillation and sports: hypothesis Dose related risk of AF in sports goes against a familial disease Genetic forms have a high penetrance and does not need the trigger effect of sport Familial forms of AF are very uncommon and a family history is rarely seen. Athletes show deep structural changes, that may explain AF withouth the need of other etiologic factors.

20 Genetic Predisposition or Genetic Disease Atrial fibrillation as a monogenic disease Atrial firillation associated with other monogenic diseases Genetic predispostion to acquired atrial fibrillation

21 ATRIAL FIBRILLATION AS A MONOGENIC DISEASE Historical Perspective Wolff L. N Engl J Med Gould WL Arch Int Med 1957 Phair WB Canad Med Ass 1963 Derrida JP et al Nouv Pres Med 1976 Wen-tai Y Chin Med J 1983 Ardiaca A et al Rev Esp Card 1987

22 I:1 I:2 FAMILIAL ATRIAL FIBRILLATION REGION SHARED ON 10q2 AFFECTED NON AFFECTED DEAD Brugada R et al NEJM, 1997

23 FAMILIAL ATRIAL FIBRILLATION CLINICAL FEATURES Mean Age of Diagnosis 18 years Range in Age of Diagnosis in utero-35 years Echocardiogram Normal Patients with Chronic AF 51/52 Asymptomatic 36/52 Heart rate bpm Brugada R et al NEJM, 1997

24 Chen YH, et al. Science 2003

25 Gussak et al. Cardiology 2000 Hong et al. JCE, 2005

26

27 Clinical Implications Each family appears to have its own gene No change in clinical approach Penetrance appears high

28 From: Association Between Familial Atrial Fibrillation and Risk of New-Onset Atrial Fibrillation JAMA. 2010;304(20): doi: /jama Date of download: 8/18/2012 Copyright 2012 American Medical Association. All rights reserved.

29 From: Association Between Familial Atrial Fibrillation and Risk of New-Onset Atrial Fibrillation JAMA. 2010;304(20): doi: /jama Date of download: 8/18/2012 Copyright 2012 American Medical Association. All rights reserved.

30 Physical activity, height and left atrial size are independent risk factors for lone atrial fibrillation in middle aged healthy individuals - Thorax Institute. Hospital Clinic, University of Barcelona - IMIM. Institut Municipal de Investigació Mèdica. Barcelona Mont L, Tamborero D, Elosua R, Molina I, Collvinent B, Sitges M, Vidal B, Scalise A, Tejeira A, Berruezo and Brugada J on behalf of the GIRAFA (Grup Integrat de Recerca en FA) investigators Mont et al. Europace 2008

31 Methods Design: Prospective, case-control study Population: 107 consecutive patients younger 18 to 65 Recent onset Lone AF, seen at the emergency room (> 48 hours). Controls: 1:1 age and sex matched controls

32 Demographic characteristics Patients N=107 Controls N= 107 Age (years) 48.0± ±10.2 Male sex (%) 74 (69%) 74 (69%) Smoking (%) 53 (50%) 53 (50%) Paroxysmal/Persistent AF (%) 61 (57%) / 46 (43%) -- Vagal AF (%) 75 (70%) -- First AF episode/ recurrent AF 46 (43%) / 61(57%) -- Number of AF episodes 4.5± AF duration (hours) 15.4±

33 Adjusted Odds ratios and 95% IC of lone AF form heavy physical activity, height and LA AP diameter Odds ratio (95% confidence interval) Cumulated intense physical activity P value 0 hours hours 1.77 ( ) > hours 7.31 ( ) Height ( ) ( ) Left atrial anteroposterior ( ) diameter (mm)

34 Sustained Endurance Training Creates a Substrate for Atrial Fibrillation in Rats Hospital Clínic. University of Barcelona Montreal Heart Institute Begoña Benito Gemma Gay Eduard Guasch Valeria Sirenko David Tamborero Anna Serrano Lluis Mont Benito et al. Circulation 2011 Sophie Cardin Yanfen Shi Patrick Lawler Ange Maguy Jean-Claude Tardif Nathalie L Heureux Chantal St-Cyr Audrey Bonard Stanley Nattel

35 Training Protocol 4 weeks 8 weeks 16 weeks Rest for 3 days Sacrifice

36 Echocardiographic data after 16 weeks of training sedentary exercise IVS thickness (cm) LV diameter (cm) 3.0 ± ± 0.1 *** 14.3 ± ± 0.3 *** LV mass (g) 18.1 ± ± 0.7 *** LA diam (SYST) LA diam (DIAST) 9.2 ± ± 0.3 *** 6.4 ± ± 0.2 * Adjusted for BSA

37 ECG parameters 16 weeks CTL (n=18) Ex (n=17) HR (bpm) 346 ± ± 11 ** PR interval (ms) 56.4 ± ± 1.8 QRS duration (ms) 23.1 ± ± 0.4 QTc interval (ms) (Bazett s) 224 ± ± 4

38 EPS parameters CTL (n=15) Ex (n=14) EP parameters Sinus cycle length (ms) ± ± 5.8 ** SN recovery time (ms) ± ± 7.1 Anterograde Wenck (ms) Atrial refractory period (ms) ± ± 4.5 ** 42.9 ± ± 1.0

39 Inducible arrhythmias Mean duration: 8.7 ± 2.0 min *

40 Protein expression of fibrotic markers in atria: Mean ± SEM;* p<0.05 (n CTL=6, n Ex=8)

41 Atrial fibrosis RA LA Ex CTL Mean ± SEM. * p<0.05; ** p<0.01; *** p<0.001

42 Summary of mechanisms Chronic high-level exercise Hemodynamic effects: Increased vagal tone Atrial overload Atrial enlargement Atrial fibrosis ATRIAL FIBRILLATION

43 Summary AF related to sports seems to be the consequence of atrial remodelling and increased vagal tone. Monogenic AF seems to be a high penetrance and not particularly linked to sport practice A genetic predisposition may be present in certain individuals.

Endurance Exercise and Cardiovascular Health

Endurance Exercise and Cardiovascular Health Endurance Exercise and Cardiovascular Health Professor Sanjay Sharma St George s University of London St George s Hospital NHS Trust sasharma@sgul.ac.uk @SSharmacardio Conflicts/Disclosures: None Objectives

More information

Device Diagnostics and Stroke Prevention: State of the Art

Device Diagnostics and Stroke Prevention: State of the Art Device Diagnostics and Stroke Prevention: State of the Art Ass. Prof. Dr. Carsten W. Israel Dept. of Cardiology Evangelical Hospital Bielefeld Germany C.W.Israel@em.uni-frankfurt.de Disclosure of Relationships

More information

Endurance training and cardiac arrhythmias

Endurance training and cardiac arrhythmias Endurance training and cardiac arrhythmias Myocardial and autonomic alterations under endurance training Federico Lombardi, MD, FESC Cardiologia, Osp. San Paolo D.M.C.O. University of Milan Milan, Italy

More information

Olivier CAZORLA. Effet délétère de l exercice sur la fonction cardiaque: modèles animaux

Olivier CAZORLA. Effet délétère de l exercice sur la fonction cardiaque: modèles animaux Olivier CAZORLA Physiologie et Médecine Expérimentale du cœur et des muscles PHYMEDEXP INSERM U1046, CNRS UMR9214, Université de Montpellier CHU Arnaud de Villeneuve Stress physiologique et physiopathologique:

More information

Long-Term Atrial Fibrillation Progression: What We Know in 2014

Long-Term Atrial Fibrillation Progression: What We Know in 2014 Long-Term Atrial Fibrillation Progression: What We Know in 2014 Advances in Cardiac Arrhythmias and Great Innovations in Cardiology XXVI Giornate Cardiologiche Torinesi Turin, 23-25 October 2014 Davide

More information

How to prevent unecessary right ventricular pacing

How to prevent unecessary right ventricular pacing How to prevent unecessary right ventricular pacing Jens Cosedis Nielsen, MD, PhD, DMSci Dept of Cardiology, Aarhus University Hospital, Skejby, Denmark June 27, 2011, Europace Madrid Conflicts of interest

More information

The Athletic Heart Takes Shape: Overview of Cardiac Remodeling Rory B. Weiner, MD

The Athletic Heart Takes Shape: Overview of Cardiac Remodeling Rory B. Weiner, MD The Athletic Heart Takes Shape: Overview of Cardiac Remodeling Rory B. Weiner, MD Cardiovascular Performance Program, MGH Assistant Professor of Medicine, Harvard Medical School Outline Athlete s Heart

More information

Atrial fibrillation and atrial flutter in athletes

Atrial fibrillation and atrial flutter in athletes OPEN ACCESS 1 Arrhythmia Unit, Department of Cardiology and Cardiovascular Surgery, University of Navarra, Navarra, Pamplona, Spain 2 Thorax Institute, Hospital Clínic, University of Barcelona, Institut

More information

April 22, 2017 Abraham Rothman, MD

April 22, 2017 Abraham Rothman, MD April 22, 2017 Abraham Rothman, MD University of Nevada School of Medicine } Definitions } Adults } Children } Heart beats } Children and adolescents who want to participate in intensive exercise. } Just

More information

Continuous ECG telemonitoring with implantable devices: the expected clinical benefits

Continuous ECG telemonitoring with implantable devices: the expected clinical benefits Continuous ECG telemonitoring with implantable devices: the expected clinical benefits C. W. Israel, M.D. Dept. of Cardiology Evangelical Hospital Bielefeld Germany Carsten.Israel@evkb.de Declaration of

More information

Exercise Cardiomyopathy

Exercise Cardiomyopathy Exercise Cardiomyopathy Aaron L. Baggish MD, F.A.C.C., F.A.C.S.M. Cardiovascular Performance Program Division of Cardiology Massachusetts General Hospital Boston, MA Conflicts: None Athletic Affiliations:

More information

François Carré Hôpital Pontchaillou -INSERM UMR1099-Université Rennes 1

François Carré Hôpital Pontchaillou -INSERM UMR1099-Université Rennes 1 Normal electrocardiogram variants in Athletes François Carré Hôpital Pontchaillou -INSERM UMR1099-Université Rennes 1 Disclosures No disclosure of interest concerning this lecture The cardiovascular sport

More information

Debate PRO. Dronedarone is an important drug in the management of paroxysmal atrial fibrillation. John Camm

Debate PRO. Dronedarone is an important drug in the management of paroxysmal atrial fibrillation. John Camm ESC ICM - Internationales Congress Center München 2012 Atrial Fibrillation Controversies in Medical Treatment Debate Dronedarone is an important drug in the management of paroxysmal atrial fibrillation

More information

Sudden Death in Athletes: What is the role of ECG Screening?

Sudden Death in Athletes: What is the role of ECG Screening? Sudden Death in Athletes: What is the role of ECG Screening? Byron K. Lee MD Professor of Medicine Director of EP Laboratory leeb@medicine.ucsf.edu Division of Cardiology Cardiac Electrophysiology Arrhythmias,

More information

Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart.

Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart. Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart. Hanne Rasmusen Consultant cardiologist, PhD Dept. of Cardiology Bispebjerg University Hospital

More information

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation 25 October 2008 Update in Electrocardiography and Arrhythmias Zian H. Tseng, M.D., M.A.S. Assistant Professor

More information

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations

Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Sports Cardiology Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Domenico Corrado, MD, PhD Inherited Arrhytmogenic Cardiomyopathy Unit Department of Cardiac, Thoracic and

More information

ARISTOTLE UNIVERSITY OF THESSALONIKI, GREECE SPORTS MEDICINE LABORATORY ΑΡΡΥΘΜΙA KAI SPORTS TO SCREEN OR NOT TO SCREEN

ARISTOTLE UNIVERSITY OF THESSALONIKI, GREECE SPORTS MEDICINE LABORATORY ΑΡΡΥΘΜΙA KAI SPORTS TO SCREEN OR NOT TO SCREEN ARISTOTLE UNIVERSITY OF THESSALONIKI, GREECE SPORTS MEDICINE LABORATORY DIRECTOR: PROF. A. DELIGIANNIS ΑΡΡΥΘΜΙA KAI SPORTS TO SCREEN OR NOT TO SCREEN EVANGELIA KOUIDI CARDIOLOGIST PROFESSOR OF SPORTS MEDICINE

More information

Atrial Fibrillation and Fibrosis: Still a strict link? Johannes Brachmann

Atrial Fibrillation and Fibrosis: Still a strict link? Johannes Brachmann Klinikum Coburg Atrial Fibrillation and Fibrosis: Still a strict link? Johannes Brachmann Prof. Dr. med. J. Brachmann Bologna 16 th February 2017 Disclosures Study Grants: Biotronik, Medtronic, SJM, Abbott,

More information

Interpretation and Consequences of Repolarisation Changes in Athletes

Interpretation and Consequences of Repolarisation Changes in Athletes Interpretation and Consequences of Repolarisation Changes in Athletes Professor Sanjay Sharma E-mail sasharma@sgul.ac.uk @SSharmacardio Disclosures: None Athlete s ECG Vagotonia Sinus bradycardia Sinus

More information

Is Atrial Fibrillation preventable?

Is Atrial Fibrillation preventable? Heart Rhythm Congress, Birmingham, 11 th October 2016 Is Atrial Fibrillation preventable? The interplay between genetic and environmental factors in genesis of AF Andrew Grace University of Cambridge -

More information

Atrial Fibrilation in the WHI and WHISH STAR

Atrial Fibrilation in the WHI and WHISH STAR Atrial Fibrilation in the WHI and WHISH STAR Marco V. Perez 5/4/2018 Stanford Division of Cardiovascular Medicine WHI Investigator Meeting 2018 Atrial Fibrillation Disorganized Atrium Most Common Arrhyth.

More information

EHRA/EUROPACE 2011 Madrid, Spain June

EHRA/EUROPACE 2011 Madrid, Spain June EHRA/EUROPACE 2011 Madrid, Spain June 26.-29.2011 Implementing modern management in atrial fibrillation patients Proceedings from the 3rd AFNet/EHRA consensus conference EHRA Special Session Different

More information

Historical Notes: Clinical Exercise Testing in the Athlete. An Efficient Heart. Structural Changes, Cont. Coronary Arteries

Historical Notes: Clinical Exercise Testing in the Athlete. An Efficient Heart. Structural Changes, Cont. Coronary Arteries Clinical Exercise Testing in the Athlete The athlete s heart Sudden cardiac death in athletes Screening athletes for cardiovascular disease Historical Notes: Giovanni Lancisi (father of cardiology), 17

More information

There are future perspectives in the pharmacological treatment of arrhythmias

There are future perspectives in the pharmacological treatment of arrhythmias There are future perspectives in the pharmacological treatment of arrhythmias George Andrikopoulos, MD, PhD, FESC, Cardiologist, Director, 1st Department of Cardiology/ Department of Electrophysiology

More information

Atrial fibrillation and advanced age

Atrial fibrillation and advanced age Atrial fibrillation and advanced age Prof. Fiorenzo Gaita Director of the Cardiology School University of Turin, Italy Prevalence of AF in the general population Prevalence and age distribution in patients

More information

EVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES

EVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES EVALUATION OF ELECTROCARDIOGRAPHIC FINDINGS IN ATHLETES UNIT OF INHERITED CV DISEASES HEART CENTER OF THE YOUNG AND ATHLETES A DPT OF CARDIOLOGY UNIVERSITY OF ATHENS EVALUATION OF ELECTROCARDIOGRAPHIC

More information

Atrial Fibrillation. Ivan Anderson, MD RIHVH Cardiology

Atrial Fibrillation. Ivan Anderson, MD RIHVH Cardiology Atrial Fibrillation Ivan Anderson, MD RIHVH Cardiology Outline Definition and Pathophysiology Rate versus rhythm control Rate control thresholds (how much is enough) Anti-coagulation CHADS2VASc score HASBLED

More information

The Athlete s Heart. Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University

The Athlete s Heart. Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University The Athlete s Heart Role of Echo Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University Washington, D.C. Disclosures Grant support (to institution) for Core

More information

The Role of ACEI and ARBs in AF prevention

The Role of ACEI and ARBs in AF prevention The Role of ACEI and ARBs in AF prevention Dr. Sameh Shaheen MD, FESC Prof. of cardiology Ain-Shams university Time course of atrial substrate remodeling in relation to the clinical appearance of AF and

More information

EVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington

EVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington EVALUATION OF THE 12 ATHLETE Karen Stout, MD Professor, Medicine and Pediatrics University of Washington NO DISCLOSURES OUTLINE Why evaluate athletes? What s the problem? What evaluation should be done?

More information

Title: Left atrium size in former elite athletes

Title: Left atrium size in former elite athletes Title: Left atrium size in former elite athletes Short title: exercise and left atrium Authors: Fabian Sanchis-Gomar, MD, PhD, a Nuria Garatachea, PhD, a,b Pilar Catalán, MD, c Marta López, MD, d Alejandro

More information

Arrhythmia/Electrophysiology. Cardiac Arrhythmogenic Remodeling in a Rat Model of Long-Term Intensive Exercise Training

Arrhythmia/Electrophysiology. Cardiac Arrhythmogenic Remodeling in a Rat Model of Long-Term Intensive Exercise Training Arrhythmia/Electrophysiology Cardiac Arrhythmogenic Remodeling in a Rat Model of Long-Term Intensive Exercise Training Begoña Benito, MD*; Gemma Gay-Jordi, PhD*; Anna Serrano-Mollar, PhD; Eduard Guasch,

More information

The 5 Most Important Things You Need to Know About Atrial Fibrillation. John D. Day, MD

The 5 Most Important Things You Need to Know About Atrial Fibrillation. John D. Day, MD The 5 Most Important Things You Need to Know About Atrial Fibrillation John D. Day, MD Disclosures Consulting with St. Jude Medical, Boston Scientific, and Biotronik The 5 Most Important Things You Need

More information

Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept.

Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept. Obesity as a risk factor for Atrial Fibrillation Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept. CardioAlex 2010 smrafla@hotmail.com 1 Obesity has reached epidemic proportions in the United

More information

Atrial Cardiomyopathy is it relevant?

Atrial Cardiomyopathy is it relevant? Atrial Cardiomyopathy is it relevant? Dr Carl Shakespeare MD FRCP FACC FESC Consultant Cardiologist Relevance Progressive nature of AF Implications for RF Targeting Risk Factors CHADS vasc scoring? Could

More information

Preventing Sudden Death Current & Future Role of ICD Therapy

Preventing Sudden Death Current & Future Role of ICD Therapy Preventing Sudden Death Current & Future Role of ICD Therapy Derek V Exner, MD, MPH, FRCPC, FACC, FAHA, FHRS Professor, Libin Cardiovascular Institute of Alberta Canada Research Chair, Cardiovascular Clinical

More information

Risk Factors for Sudden cardiac Death

Risk Factors for Sudden cardiac Death Risk Factors for Sudden cardiac Death A. Arenal Arrhythmias in competitive sports Disclosure Conflict of interest Advisory board: Medtronic, Boston Scientific Research grants: Medtronic, Boston Scientific,

More information

13/09/2018. The ISSUE Studies. International (Italy & Spain) Study of Syncope of Uncertain Etiology. ISSUE study Pre-defined inclusion cathegories

13/09/2018. The ISSUE Studies. International (Italy & Spain) Study of Syncope of Uncertain Etiology. ISSUE study Pre-defined inclusion cathegories The Studies Jean-Claude Deharo Aix-Marseille Université, France In Cardiac Electrophysiology Methods and Models Editors: Daniel C. Sigg, Paul A. Iaizzo, Yong-Fu Xiao, Bin He Springer 2010 study Pre-defined

More information

Saudi Heart Association February 22, 2011

Saudi Heart Association February 22, 2011 Pharmacological Therapy of Atrial Fibrillation: Recent Advances Dr Martin Green Professor of Medicine (Cardiology) University of Ottawa Saudi Heart Association February 22, 2011 Atrial Fibrillation Drugs

More information

«Aσθενής με ασυμπτωματικό WPW και παροξυσμική κολπική μαρμαρυγή» Χάρης Κοσσυβάκης Επιμελητής A Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.

«Aσθενής με ασυμπτωματικό WPW και παροξυσμική κολπική μαρμαρυγή» Χάρης Κοσσυβάκης Επιμελητής A Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. «Aσθενής με ασυμπτωματικό WPW και παροξυσμική κολπική μαρμαρυγή» Χάρης Κοσσυβάκης Επιμελητής A Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ» the primary mechanism of SCD in patients with WPW is the rapid conduction

More information

Prevention of Sudden Death in ARVC

Prevention of Sudden Death in ARVC ESC Munich, August 29, 2012 Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Prevention of Sudden Death in ARVC Thomas Wichter, MD, FESC Professor of Medicine - Cardiology Marienhospital Osnabrück

More information

Summary, conclusions and future perspectives

Summary, conclusions and future perspectives Summary, conclusions and future perspectives Summary The general introduction (Chapter 1) of this thesis describes aspects of sudden cardiac death (SCD), ventricular arrhythmias, substrates for ventricular

More information

The Athlete s Heart. Critical Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University

The Athlete s Heart. Critical Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University The Athlete s Heart Critical Role of Echo Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University Washington, D.C. Disclosures Grant support (to institution)

More information

Post-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring

Post-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring Catheter Ablation of Atrial Fibrillation: State of the Art Post-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring Dipen Shah Service de Cardiologie Hospital Cantonal de Genève

More information

Ablation of persistent AF Is it different than paroxysmal?

Ablation of persistent AF Is it different than paroxysmal? Ablation of persistent AF Is it different than paroxysmal? Steven J. Kalbfleisch, MD Medical Director Electrophysiology Laboratory Ohio State University Wexner Medical Center Ross Heart Hospital Columbus,

More information

AF Ablation in Patients with Heart Failure

AF Ablation in Patients with Heart Failure AF Ablation in Patients with Heart Failure Christian de Chillou, MD, PhD Department of Cardiology University Hospital Nancy, France 28ème Journée Internationale du Centre Cardio-Thoracique de Monaco Monaco,

More information

SABIHA GATI AND SANJAY SHARMA

SABIHA GATI AND SANJAY SHARMA 9 The athlete s heart SABIHA GATI AND SANJAY SHARMA Pasieka/Science Photo Library In this article, the authors highlight the spectrum, magnitude and determinants of the athlete s heart and provide a practical

More information

Atrial fibrillation and stroke. Isabelle C Van Gelder University Medical Center Groningen The Netherlands

Atrial fibrillation and stroke. Isabelle C Van Gelder University Medical Center Groningen The Netherlands Atrial fibrillation and stroke Isabelle C Van Gelder University Medical Center Groningen The Netherlands ESC stroke council Prague January 2018 Content Stroke what is the problem for patients with AF?

More information

Cardiovascular Impacts of long-term endurance exercise: Implications of athlete s heart

Cardiovascular Impacts of long-term endurance exercise: Implications of athlete s heart Cardiovascular Impacts of long-term endurance exercise: Implications of athlete s heart Dr. Gary Mak 麥耀光心臟科專科醫生 IPP of HK Associa4on of Sports Medicine and Sports Science Director of Pro-Cardio Heart Disease

More information

DRS ed Aritmie Cardiache Iper ed Ipocinetiche: la clinica

DRS ed Aritmie Cardiache Iper ed Ipocinetiche: la clinica Corso Multidisciplinare di Aggiornamento La Sindrome delle Apnee Notturne: una sfida diagnostico terapeutica DRS ed Aritmie Cardiache Iper ed Ipocinetiche: la clinica FRANCESCO PERNA, MD, PhD Laboratorio

More information

Subclinical AF: Implications of device based episodes

Subclinical AF: Implications of device based episodes Subclinical AF: Implications of device based episodes Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC Disclosures: Clinical Trials and Consulting: Medtronic, Boston Scientific

More information

Debate: Asymptomatic Patients with Ventricular Preexcitation Require EP Testing for Risk Stratification. Carlo Pappone, MD, PhD, FACC

Debate: Asymptomatic Patients with Ventricular Preexcitation Require EP Testing for Risk Stratification. Carlo Pappone, MD, PhD, FACC Debate: Asymptomatic Patients with Ventricular Preexcitation Require EP Testing for Risk Stratification Carlo Pappone, MD, PhD, FACC The Wolff-Parkinson-White Syndrome Demographics Δ waves detectable on

More information

A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC

A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC AF Clinical/Referral Challenge Asymptomatic 40% 3 Rx Effective 30% Failed Rx Ablation Atrial fibrillation (AF) is the most common Candidate

More information

The frontier between normal and abnormal electrocardiogram in athletes

The frontier between normal and abnormal electrocardiogram in athletes The frontier between normal and abnormal electrocardiogram in athletes ESC Congress 2011 Paris F. Carré University Rennes 1-Pontchaillou Hospital Inserm U642, Rennes - F-35000 Cardiovascular preparticipation

More information

Interventional solutions for atrial fibrillation in patients with heart failure

Interventional solutions for atrial fibrillation in patients with heart failure Interventional solutions for atrial fibrillation in patients with heart failure Advances in Cardiovascular Arrhythmias Great Innovations in Cardiology Matteo Anselmino, MD PhD Division of Cardiology Department

More information

Sabri DEMIRCAN Istanbul Bilim University Department of Cardiology

Sabri DEMIRCAN Istanbul Bilim University Department of Cardiology abri DEMIRCN Istanbul Bilim University Department of Cardiology H/CC/HR Guideline for the Management of Patients With trial Fibrillation. J m Coll Cardiol 4;64:46-8. European Heart Journal () 3, 369-49

More information

Physical Activity and Coronary calcification ADJ ASSOCIATE PROFESSOR TAN SWEE YAW NATIONAL HEART CENTRE SINGAPORE

Physical Activity and Coronary calcification ADJ ASSOCIATE PROFESSOR TAN SWEE YAW NATIONAL HEART CENTRE SINGAPORE Physical Activity and Coronary calcification ADJ ASSOCIATE PROFESSOR TAN SWEE YAW NATIONAL HEART CENTRE SINGAPORE Calcium Scores (CACS) Calcium Scores (CACS) Calcium Scores are indicative of the presence

More information

Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes

Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes Europace (2010) 12, 30 36 doi:10.1093/europace/eup320 CLINICAL RESEARCH Ablation for Atrial Fibrillation Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes

More information

at least 4 8 hours per week

at least 4 8 hours per week ECG IN ATHLETS An athlete is defined as an individual who engages in regular exercise or training for sport or general fitness, typically with a premium on performance, and often engaged in individual

More information

How atrial fibrillation should be treated in the heart failure patient?

How atrial fibrillation should be treated in the heart failure patient? Advances in Cardiac Arrhhythmias and Great Innovations in Cardiology Torino, 13/15 Ottobre 2016 How atrial fibrillation should be treated in the heart failure patient? Matteo Anselmino Dipartimento Scienze

More information

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro Jerónimo Farré MD, Madrid, ES AF: the kingdom of wishful thinking In AF we

More information

Atrial Fibrillation Promotion by Endurance Exercise Demonstration and Mechanistic Exploration in an Animal Model

Atrial Fibrillation Promotion by Endurance Exercise Demonstration and Mechanistic Exploration in an Animal Model Journal of the American College of Cardiology Vol. 62, No. 1, 2013 Ó 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2013.01.091

More information

ANTIPAF Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation Trial

ANTIPAF Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation Trial European Society of Cardiology Hotline Stockholm - Zone K 31 st August 2010 Placebo ARB Kumagai K, et al. JACC 2003 Discussant ANTIPAF Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation Trial

More information

DON T FORGET TO OPTIMISE DEVICE PROGRAMMING

DON T FORGET TO OPTIMISE DEVICE PROGRAMMING CRT:NON-RESPONDERS OR NON-PROGRESSORS? DON T FORGET TO OPTIMISE DEVICE PROGRAMMING Prof. ALİ OTO,MD,FESC,FACC,FHRS Chairman,Department of Cardiology Hacettepe University Faculty of Medicine,Ankara Causes

More information

Atrial Fibrillation and You

Atrial Fibrillation and You Atrial Fibrillation and You Dr Matthew Fay General Practitioner AFA Medical Advisory Committee Member NHS-Improvement Clinical Lead AF & U Dr Matthew Fay General Practitioner AFA Medical Advisory Committee

More information

Athletes with cardiac disease; dead and buried or chance for resurrection?

Athletes with cardiac disease; dead and buried or chance for resurrection? Athletes with cardiac disease; dead and buried or chance for resurrection? EuroPRevent 2011 Geneva F. Carré University Rennes 1-Pontchaillou Hospital Inserm U642, Rennes - F-35000 Risk of physical activity

More information

Current ECG interpretation guidelines in the screening of athletes

Current ECG interpretation guidelines in the screening of athletes REVIEW ARTICLE 7 How to differentiate physiological adaptation to intensive physical exercise from pathologies Current ECG interpretation guidelines in the screening of athletes Gemma Parry-Williams, Sanjay

More information

Catheter ablation in AF patients with heart failure. What is possible?

Catheter ablation in AF patients with heart failure. What is possible? Catheter ablation in AF patients with heart failure What is possible? Sébastien Knecht, MD PhD Hôpital cardiologique du Haut L Evêque, Bordeaux HEART FAILURE AND AF Ehrlich. JCE 2002 (13): 399-405, Wang

More information

Athlete s Heart: Clinical Relevance. Athlete's Heart vs. Cardiac Pathology Clinical Approaches. Echo Florida Conflicts of Interest: None

Athlete s Heart: Clinical Relevance. Athlete's Heart vs. Cardiac Pathology Clinical Approaches. Echo Florida Conflicts of Interest: None Athlete's Heart vs. Cardiac Pathology Clinical Approaches Echo Florida 2012 Aaron L. Baggish MD Cardiovascular Performance Program Cardiac Ultrasound Laboratory Division of Cardiology Massachusetts General

More information

Rational Approach to Improving Cardiac Arrhythmia Therapy. Rational Approach to Improving Cardiac Arrhythmia Therapy

Rational Approach to Improving Cardiac Arrhythmia Therapy. Rational Approach to Improving Cardiac Arrhythmia Therapy Rational Approach to Improving Cardiac Arrhythmia Therapy Rational Approach to Improving Cardiac Arrhythmia Therapy Stanley Nattel, MD Stanley Nattel, MD DEDICATED TO THE MASTER OF RATIONAL THERAPEUTICS

More information

Athlete s Heart vs. Cardiomyopathy

Athlete s Heart vs. Cardiomyopathy Athlete s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular Service Line Former Team Cardiologist to the New York Jets

More information

Brazilian Journal of Biomotricity ISSN: Universidade Iguaçu Brasil

Brazilian Journal of Biomotricity ISSN: Universidade Iguaçu Brasil Brazilian Journal of Biomotricity ISSN: 1981-6324 marcomachado@brjb.com.br Universidade Iguaçu Brasil Kaur, Kulroop EFFECT OF STRENGTH TRAINING ON LEFT ATRIUM IN WRESTLERS Brazilian Journal of Biomotricity,

More information

AF ABLATION Concepts and Techniques

AF ABLATION Concepts and Techniques AF ABLATION Concepts and Techniques Antony F Chu, M.D. Director of Complex Ablation Arrhythmia Services Section Division of Cardiology at the Rhode Island and Miriam Hospital HIGHLIGHTS The main indications

More information

This is What I do to Improve CRT Response for CRT Non-Responders

This is What I do to Improve CRT Response for CRT Non-Responders This is What I do to Improve CRT Response for CRT Non-Responders Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC Disclosures: Steering Committees (unpaid) and Clinical Trials,

More information

Heart Rate Recovery in association with exercise stress testing

Heart Rate Recovery in association with exercise stress testing Heart Rate Recovery in association with exercise stress testing Daniel E. Forman, M.D. Director, Exercise Laboratory Brigham and Women s Hospital April 21, 2006 Stress Testing Historical Rationale for

More information

Outline. Many Health Benefits of exercise for all ages. Over age 35 years- drawn to endurance exercise. Risks of exercise

Outline. Many Health Benefits of exercise for all ages. Over age 35 years- drawn to endurance exercise. Risks of exercise Outline Sports Cardiology In Endurance Athletes AKOMA CME Conference 5-1-14 Anchorage AK Christine E. Lawless, MD, MBA, FACC, FACSM, CAQSM Founder, ACC Sports and Exercise Cardiology Council President-Sports

More information

Atrial Remodeling, Autonomic Tone, and Lifetime Training Hours in Nonelite Athletes

Atrial Remodeling, Autonomic Tone, and Lifetime Training Hours in Nonelite Athletes Atrial Remodeling, Autonomic Tone, and Lifetime Training Hours in Nonelite Athletes Matthias Wilhelm, MD a, *, Laurent Roten, MD b, Hildegard Tanner, MD b, Ilca Wilhelm, MD c, Jean-Paul Schmid, MD a, and

More information

Right ventricular adaptation in endurance athletes. António Freitas. No conflict of interest

Right ventricular adaptation in endurance athletes. António Freitas. No conflict of interest The role of echocardiography in sports cardiology Right ventricular adaptation in endurance athletes. António Freitas Cardiology Department - Fernando Fonseca Hospital Lisbon Sports Medicine Centre - Lisbon

More information

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes Francis Marchlinski, MD Richard T and Angela Clark President s Distinguished Professor Director Cardiac Electrophysiolgy University

More information

Normal ECG And ECHO Findings in Athletes

Normal ECG And ECHO Findings in Athletes Normal ECG And ECHO Findings in Athletes Dr.Yahya Kiwan Consultant Interventional Cardiologist Head Of Departement Of Cardiology Canadian Specialist Hospital Sinus Bradycardia The normal heartbeat is initiated

More information

Declaration of conflict of interest. None to declare

Declaration of conflict of interest. None to declare Declaration of conflict of interest None to declare Risk management of coronary artery disease Arrhythmias and diabetes Hercules Mavrakis Cardiology Department Heraklion University Hospital Crete, Greece

More information

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology Atrial Fibrillation: Rate vs. Rhythm Michael Curley, MD Cardiac Electrophysiology I have no relevant financial disclosures pertaining to this topic. A Fib Epidemiology #1 Most common heart rhythm disturbance

More information

Ventricular tachyarrhythmias induced by exercise: are they an unsafe clinical pattern?

Ventricular tachyarrhythmias induced by exercise: are they an unsafe clinical pattern? Ventricular tachyarrhythmias induced by exercise: are they an unsafe clinical pattern? Alessandro Biffi Istitute of Sports Medicine and Science Italian Olympic Commitee Rome, Italy A complex interaction

More information

ICD in a young patient with syncope

ICD in a young patient with syncope ICD in a young patient with syncope Konstantinos P. Letsas, MD, FESC Second Department of Cardiology Evangelismos General Hospital of Athens Athens, Greece Case presentation A 17-year-old apparently healthy

More information

Dr Navin Chandra Clinical Research Fellow in Cardiology St George s University of London

Dr Navin Chandra Clinical Research Fellow in Cardiology St George s University of London Dr Navin Chandra Clinical Research Fellow in Cardiology St George s University of London Cardiac Adaptation in Athletes Athletic training for prolonged periods may result in physiological adaptations of

More information

Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm

Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm Guy Amit, MD, MPH Soroka University Medical Center Ben-Gurion University of the Negev Beer-Sheva, Israel Disclosures Consultant:

More information

FA et Apnée du Sommeil

FA et Apnée du Sommeil FA et Apnée du Sommeil La Réunion Octobre 2017 Pascal Defaye CHU Grenoble-Alpes Obstructive Sleep Apnea and AF Incidence of atrial fibrillation (AF), based on presence or absence of OSA. Cumulative frequency

More information

Left Atrial Appendage Closure: The Rationale

Left Atrial Appendage Closure: The Rationale Left Atrial Appendage Closure: The Rationale JOHN D. HUMMEL, MD DIRECTOR OF CLINCAL ELECTROPHYSIOLOGY RESEARCH PROFESSOR OF CLINICAL INTERNAL MEDICINE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER 1 Disclosures

More information

Anodal Capture in Cardiac Resynchronization Therapy Implications for Device Programming

Anodal Capture in Cardiac Resynchronization Therapy Implications for Device Programming Anodal Capture in Cardiac Resynchronization Therapy Implications for Device Programming DAVID TAMBORERO,* LLUIS MONT,* ROBERTO ALANIS, ANTONIO BERRUEZO,* JOSE MARIA TOLOSANA,* MARTA SITGES,* BARBARA VIDAL,*

More information

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines Christophe Tribouilloy Amiens, France I have no financial relationships to disclose related

More information

Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy

Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Evan Adelstein, MD, FHRS John Gorcsan III, MD Samir Saba, MD, FHRS

More information

Catheter Ablation for Treatment of Atrial Fibrillation 2010 and Beyond

Catheter Ablation for Treatment of Atrial Fibrillation 2010 and Beyond Catheter Ablation for Treatment of Atrial Fibrillation 2010 and Beyond John M. Miller, MD Professor of Medicine Indiana University School of Medicine Director, Clinical Cardiac Electrophysiology Krannert

More information

Asymptomatic patient with WPW

Asymptomatic patient with WPW Asymptomatic patient with WPW Dimosthenis Avramidis, MD. Arrythmiologist Mitera Children s Hospital Athens Greece Scientific Associate 1st Cardiology Dpt Evangelismos Hospital Athens Greece Preexcitation

More information

His Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017

His Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017 His Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017 Conflicts Medtronic: Research, Honoraria, Consulting Boston Scientific: Research,

More information

Atrial Fibrillation. Why It s Important. Updated on 2007 / 11 / 23. Microlife Corp ww.microlife.com. Page 1

Atrial Fibrillation. Why It s Important. Updated on 2007 / 11 / 23. Microlife Corp ww.microlife.com. Page 1 Atrial Fibrillation Why It s Important Microlife Corp ww.microlife.com Updated on 2007 / 11 / 23 Page 1 CONTENT ORIGINAL PRESENTATION P3 ~ P13 UPDATED ASH ABSTRACT SUBMISSION INFORMATION INTERESTING LINK

More information

J-wave syndromes: update on ventricular fibrillation mechanisms

J-wave syndromes: update on ventricular fibrillation mechanisms J-wave syndromes: update on ventricular fibrillation mechanisms Michael Nabauer University of Munich, Germany 28.8.2011 I have no conflicts of interest ECG labelling by Einthoven Circ 1998 Osborn wave

More information

Athlete s Heart vs. Cardiomyopathy

Athlete s Heart vs. Cardiomyopathy Athlete s Heart vs. Cardiomyopathy Linda D. Gillam, MD, MPH, FASE Chair, Department of Cardiovascular Medicine Medical Director, Cardiovascular Service Line Former Team Cardiologist to the New York Jets

More information

Abnormal ECG patterns and significance in a group of mountaineers

Abnormal ECG patterns and significance in a group of mountaineers Original Article Abnormal ECG patterns and significance in a group of mountaineers Wg Cdr V Vasdev*, Wg Cdr DS Chadha +, Gp Capt P Kharbanda #, Lt Col SK Datta**, Air Cmde RK Ganjoo AVSM VSM ++ ABSTRACT

More information

Left ventricular non-compaction: the New Cardiomyopathy on the Block

Left ventricular non-compaction: the New Cardiomyopathy on the Block Left ventricular non-compaction: the New Cardiomyopathy on the Block Aamir Jeewa MB BCh, FAAP, FRCPC Section Head, Cardiomyopathy & Heart Function Program The Hospital for Sick Children Assistant Professor

More information